Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
ARK Invest: In April, BTC Outperformed the S&P 500, Price Retracted but Rebounded Quickly

ARK Invest: In April, BTC Outperformed the S&P 500, Price Retracted but Rebounded Quickly

ChaincatcherChaincatcher2025/05/07 15:20
Show original

ARK Investment Management released a Bitcoin reading report for April 2025, which noted that inflation, market sentiment, and tariffs send mixed signals about the economic outlook. However, data shows that Bitcoin prices rose by about 14% in April, outperforming the S&P 500 index, and quickly rebounded from market panic triggered by tariffs.

The report also mentioned that the current price correction of Bitcoin has not exceeded 30%, technically remaining in a bull market range. If it falls 30%, 50%, and 70% from the historical high, the corresponding price levels would be approximately $74,311, $53,080, and $31,848, respectively.

Additionally, the number of unrealized loss Bitcoins held by long-term holders (LTH) is close to 3.5 million, the highest level since 2018, indicating that the market may be in an oversold state, with ARK holding a "bullish" view on this. The report also mentioned that the current profitable supply ratio of Bitcoin has not exceeded 68%, far below the level of over 80% at historical peaks, indicating no signs of irrational exuberance in the market. Overall, on-chain data reflects that the market is in a healthy consolidation phase.

 
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Vietnam VN Index closed down 0.6%

格隆汇•2026/10/26 08:09
Vietnam VN Index closed down 0.6%

Windward Bio (WWB.US) plans to list in the US and aims to raise up to 100 million dollars, with multiple drugs licensed to Chinese pharmaceutical companies.

Windward Bio Group filed for an initial public offering (IPO) with the U.S. Securities and Exchange Commission (SEC) last Friday, aiming to raise up to 100 million dollars.

智通财经•2026/10/26 07:31
Windward Bio (WWB.US) plans to list in the US and aims to raise up to 100 million dollars, with multiple drugs licensed to Chinese pharmaceutical companies.

A Contrarian Amid the Selloff in French Bonds: 370 billion AUD Pension Fund Increases Holdings, Betting That Fiscal Risks Are Overestimated

Australia's second largest pension fund is buying French government bonds. The institution believes that the market has overreacted in pricing France's fiscal predicament and the European Central Bank's interest rate hike outlook.

智通财经•2026/10/26 07:21